Religiosity aspects in patients with epilepsy
Glória Maria Almeida Souza Tedrus1, Lineu Corrêa Fonseca1, Tatiane Mariani Fagundes2
1School of Medicine, Pontifical Catholic University of Campinas (PUC-Campinas), Brazil.
Epilepsy & Behavior : E&B
|July 3, 2015
Summary
This study found that religiosity levels differ between patients with epilepsy and controls. Specific aspects of religiosity, like intrinsic and nonorganizational religiosity, are linked to epilepsy type and seizure control.
Area of Science:
- Neuroscience
- Psychology
- Sociology
Background:
- Epilepsy affects a significant portion of the global population.
- Understanding the psychosocial factors influencing epilepsy management is crucial.
- Religiosity is a significant aspect of many individuals' lives and may impact health outcomes.
Purpose of the Study:
- To assess religiosity in patients with epilepsy (PWEs) and controls.
- To determine relationships between religiosity and clinical, sociodemographic, and quality of life data in PWEs.
Main Methods:
- Administered the Duke Religion Index to 159 adult PWEs and 50 controls.
- Compared religiosity measures (intrinsic, organizational, nonorganizational) between groups.
- Used logistic regression to identify predictors of religiosity and associations with epilepsy characteristics.
Main Results:
- Patients with epilepsy exhibited higher intrinsic religiosity (IR) and nonorganizational religiosity (NOR) than controls.
- Female gender and mesial temporal lobe epilepsy with hippocampus sclerosis (MTLE-HS) predicted high organizational religiosity (OR).
- MTLE-HS was associated with higher NOR and IR, and with controlled seizures. No correlation was found between religiosity and QOLIE-31 scores.
Conclusions:
- Specific forms of interictal religiosity are associated with distinct clinical features of epilepsy.
- Religiosity may play a role in the experience and management of epilepsy, particularly in specific subtypes.
- Further research is needed to explore the complex interplay between religiosity and epilepsy.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.7K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
01:13Seizures: Classification
2.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.3K
01:08Antiepileptic Drugs: Sodium Channel Blockers
2.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K